ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

miR-182 as a Prognostic Marker for Glioma Progression and Patient Survival

Jiang Lili; Mao Pu; Song Libing; Wu Jueheng; Huang Jieting; Lin Chuyong; Yuan Jie; Qu Lianghu; Cheng Shi Yuan; Li Jun*
AMERICAN JOURNAL OF PATHOLOGY2010-7DOI: 10.2353/ajpath.20.10.090812
77被引4阅读
引用收藏
分享

摘要

Accumulating evidence indicates that miRNA expression can be used as a diagnostic and prognostic marker for human cancers. We report that the expression level of miR-182 was markedly up-regulated in glioma cell lines and in human primary glioma specimens. Quantitative PCR analysis showed that miR182 was significantly increased by up to 32-fold in glioma tumors compared with the adjacent nontumor brain tissues obtained from the same patient. Elevated expression of miR-182 was further identified by in situ hybridization in 248 of 253 (98%) archived human glioma biopsies tested. Statistical analysis revealed a significant correlation between miR-182 expression and World Health Organization glioma grading (P < 0.001). The cumulative 5-year survival rate of glioma patients was 51.54% (95% confidence interval, 0.435 to 0.596) in the low miR-182-expression group, whereas it was only 7.23% (95% confidence interval, 0.027 to 0.118) in the high miR-182-expression group (P = 0.001), and multivariate Cox regression analysis indicated that miR-182 expression was an independent prognostic indicator for the survival of glioma patients. Moreover, the correlations of miR-182 level with the clinical features of glioma suggested in the in situ hybridization analysis were further verified by the real-time RT-PCR analysis. Taken together, our results suggest that miR-182 could be a valuable marker of glioma progression and that high miR-182 expression is associated with poor overall survival in patients with malignant glioma. (Am J Pathol 2010, 177:29-38 DOI: 10.2353/ajpath.2010.090812)

相关
加载中…
  • Downregulation of miR-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas
    Liu Liping; Chen Kun; Wu Jueheng; Shi Ling; Hu Bo; Cheng Shiyuan; Li Mengfeng; Song Libing*Clinical Cancer Research, 2013, 19(13): 3429-3438.被引 7
  • TGF-beta induces miR-182 to sustain NF-kappa B activation in glioma subsets
    Song Libing; Liu Liping; Wu Zhiqiang; Li Yun; Ying Zhe; Lin Chuyong; Wu Jueheng; Hu Bo; Cheng Shi Yuan; Li Mengfeng; Li Jun*Journal of Clinical Investigation, 2012, 122(10): 3563-3578.被引 46
  • Comprehensive Analysis of Expression and Prognostic Value of MS4As in Glioma
    Zeng, Yingying; Tan, Peixin; Ren, Chen; Gao, Lianxuan; Chen, Yulei; Hu, Shushu; Tang, Nan; Chen, Chen; Du, Shasha*Frontiers in Genetics, 2022, 13: 795844.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
AMERICAN JOURNAL OF PATHOLOGY
发表日期
2010-07
卷期
第 177 卷, 第 1 期
页码
29-38
DOI
10.2353/ajpath.20.10.090812
语言
ENGLISH
成果收录
SCI
资助标注
Ministry of Science and Technology of China(973) [2005CB724605]; Natural Science Foundation of China [30670803, 30770836, 30771110, 30870963, 30831160517]; Program for New Century Excellent Talents in Universities [NCET-07-0877]; Science and Technology Department of Guangdong Province, China [07001503, 8251008901000006, 2008A030201006]; Ministry of Education of China [(2008)890, 200805580047]; Science and Technology Department of Zhuhai Municipality; Guangdong Provincial Natural Science Foundation; US NIH [CA102011, CA130966]; ACS RSG [CSM-107111]

作者

  • J

    Jiang Lili (第一作者)

  • M

    Mao Pu

查看全部 10 位作者收起作者
  • S

    Song Libing

  • W

    Wu Jueheng

  • H

    Huang Jieting

  • L

    Lin Chuyong

  • Y

    Yuan Jie

  • Q

    Qu Lianghu

  • C

    Cheng Shi Yuan

  • L

    Li Jun (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417